Organogenesis Holdings (ORGO) Retained Earnings (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Retained Earnings of -$56.2 million for Q1 2026, up 4.61% year-over-year from -$53.8 million in Q1 2025, and down 1726.97% quarter-over-quarter from -$3.1 million in Q4 2025.
Organogenesis Holdings (ORGO) Retained Earnings (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Retained Earnings history runs 12 years deep, the most recent figure standing at -$56.2 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 4.61% year-over-year to -$56.2 million; the TTM figure through Mar 2026 stood at -$56.2 million (up 4.61% YoY), while the FY2025 annual figure was -$3.1 million, up 92.33% from the prior year.
- Retained Earnings for Q1 2026 stood at -$56.2 million, down from -$3.1 million in the prior quarter.
- The five-year high for Retained Earnings was -$3.1 million in Q4 2025, with the low at -$68.3 million in Q2 2025.
- The 5-year median for Retained Earnings is -$47.8 million (2024), against an average of -$47.7 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 37.97% in 2024, then soared 92.33% in 2025.
- Organogenesis Holdings' Retained Earnings stood at -$45.3 million in 2022, then increased by 9.56% to -$41.0 million in 2023, then advanced by 2.1% to -$40.1 million in 2024, then jumped by 92.33% to -$3.1 million in 2025, then plunged by 1726.97% to -$56.2 million in 2026.
- Business Quant data shows ORGO's Retained Earnings at -$56.2 million in Q1 2026, -$3.1 million in Q4 2025, and -$46.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | -152.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -152.50 Mn |
| Mar 31, 2026 | -56.23 Mn |
| Dec 31, 2025 | -3.08 Mn |
| Sep 30, 2025 | -46.78 Mn |
| Jun 30, 2025 | -68.35 Mn |
| Mar 31, 2025 | -58.95 Mn |
| Dec 31, 2024 | -40.11 Mn |
| Sep 30, 2024 | -47.78 Mn |
| Jun 30, 2024 | -60.11 Mn |
| Mar 31, 2024 | -43.07 Mn |
| Dec 31, 2023 | -40.97 Mn |
| Sep 30, 2023 | -40.40 Mn |
| Jun 30, 2023 | -43.57 Mn |
| Mar 31, 2023 | -48.89 Mn |
| Dec 31, 2022 | -45.30 Mn |
| Sep 30, 2022 | -52.79 Mn |
| Jun 30, 2022 | -53.00 Mn |
| Mar 31, 2022 | -61.75 Mn |
| Dec 31, 2021 | -60.83 Mn |
| Sep 30, 2021 | -111.83 Mn |